Literature DB >> 9428846

Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?

C W Whitten1, G E Hill, R Ivy, P E Greilich, J M Lipton.   

Abstract

UNLABELLED: Cardiopulmonary bypass (CPB) induces a systemic inflammatory response characterized by release of proinflammatory cytokines, including interleukin 6 (IL-6). Recent reports suggest that plasma IL-6 is increased after CPB. Previous studies evaluating the influence of duration of CPB and/or aortic cross-clamp time on the release of IL-6 are conflicting. Infusion of blood and blood products during these studies may have influenced plasma concentrations of proinflammatory cytokines by inducing host cell (monocyte) activation and IL-6 release. The purpose of our investigation was to determine, in an environment free from blood and/or blood product administration, the influence of duration of CPB and/or aortic cross-clamp on the magnitude of the IL-6 response in patients undergoing cardiac surgery. We prospectively evaluated plasma IL-6 levels preinduction (T0) and at sternal closure in 16 patients undergoing CPB (coronary artery bypass grafting, n = 9; valvular cardiac surgery, n = 7) to determine whether there is a correlation between the absolute increase in IL-6 and the duration of CPB or aortic cross-clamp time. None of the patients received blood and/or blood products during the study to control for the introduction of additional activated cells and soluble mediators, including IL-6. The results demonstrate that the magnitude of the IL-6 response to CPB is positively correlated with the duration of CPB but not with duration of aortic cross-clamp. It seems that induction of IL-6 release is part of a normal response to CPB and does not depend on activation of host cells during prolonged aortic cross-clamp. The activation or presence of inflammatory cytokines associated with administration of blood and/or blood products could have influenced previously published investigations relating the influence of duration of CPB and/or aortic cross-clamp time to the magnitude of the IL-6 response. IMPLICATIONS: This study found a positive correlation between the magnitude of the interleukin 6 response to cardiopulmonary bypass and duration of cardiopulmonary bypass (but not duration of aortic cross-clamp) when measurements were made in the absence of blood/blood product transfusion. Future studies evaluating strategies to reduce cytokine responses to cardiopulmonary bypass should therefore control for cardiopulmonary bypass duration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9428846     DOI: 10.1097/00000539-199801000-00006

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

1.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.

Authors:  D J Brull; J Sanders; A Rumley; G D Lowe; S E Humphries; H E Montgomery
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery.

Authors:  Jenni M Williams; Paul Young; Janine Pilcher; Mark Weatherall; John Holmes Miller; Richard Beasley; Anne Camille La Flamme
Journal:  Heart Asia       Date:  2012-08-13

3.  Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery.

Authors:  Serdar Celebi; Ozge Koner; Ferdi Menda; Huriye Balci; Alican Hatemi; Kubilay Korkut; Figen Esen
Journal:  Intensive Care Med       Date:  2006-04-28       Impact factor: 17.440

4.  Lymphatic pump treatment repeatedly enhances the lymphatic and immune systems.

Authors:  Artur Schander; David Padro; Hollis H King; H Fred Downey; Lisa M Hodge
Journal:  Lymphat Res Biol       Date:  2013-12       Impact factor: 2.589

5.  Protective effect of silymarin during coronary artery bypass grafting surgery.

Authors:  Tagreed Altaei
Journal:  Exp Clin Cardiol       Date:  2012

6.  Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.

Authors:  J M Balaguer; C Yu; J G Byrne; S K Ball; M R Petracek; N J Brown; M Pretorius
Journal:  Clin Pharmacol Ther       Date:  2012-12-24       Impact factor: 6.875

7.  Concomitant cardiac surgery procedures during left ventricular assist device implantation: single-centre experience.

Authors:  Julia Riebandt; Anne Schaefer; Dominik Wiedemann; Thomas Schlöglhofer; Günther Laufer; Sigrid Sandner; Daniel Zimpfer
Journal:  Ann Cardiothorac Surg       Date:  2021-03

8.  Approach to postoperative fever in pediatric cardiac patients.

Authors:  Ajay K Gupta; Vishal K Singh; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2012-01

9.  Outcomes in patients undergoing complex cardiac repairs with cross clamp times over 300 minutes.

Authors:  Blake Shultz; Tomasz Timek; Alan T Davis; John Heiser; Edward Murphy; Charles Willekes; Robert Hooker
Journal:  J Cardiothorac Surg       Date:  2016-07-12       Impact factor: 1.637

10.  Identification of clinical factors predicting warfarin sensitivity after cardiac surgery.

Authors:  Karen Tyson; Nevil Hutchinson; Sian Williams; Greg Scutt
Journal:  Ther Adv Drug Saf       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.